Department of Microbiology and Immunology, The University of Texas Medical Branch at Galveston, Galveston, Texas 77555-10191; First Department of Internal Medicine, Kanazawa University, Kanazawa, Japan2; and Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 275993
Received 16 September 1998/Accepted 4 March 1999
The 5' nontranslated RNA (5'NTR) of a genotype 1b hepatitis C virus
(HCV-N) directs cap-independent translation of the HCV-N polyprotein
with about twofold less efficiency than the 5'NTR of a genotype
1a virus under physiologic conditions (Hutchinson strain, or
HCV-H) (M. Honda et al., Virology 222:31-42,
1996). Here, we show by mutational analysis that substitution
of the AG dinucleotide sequence at nucleotides (nt) 34 and 35
of HCV-N with GA (present in HCV-H) restores the translational
activity to that of the HCV-H 5'NTR both in vitro and in vivo.
These nucleotides are located upstream of the minimal essential
internal ribosome entry site (IRES), as a 6-nt deletion spanning
nt 32 to 37 also increased the translational activity of the
HCV-N 5'NTR to that of HCV-H. Thus, the upstream AG dinucleotide
sequence has an inhibitory effect on IRES-directed translation.
Surprisingly, however, this inhibitory effect was observed only
when the translated, downstream RNA sequence contained nt 408
to 929 of HCV (capsid-coding RNA). Further analysis of RNA transcripts
containing frameshift mutations demonstrated that the nucleotide
sequence of the transcript, and not the amino acid sequence
of the expressed capsid protein, determines this difference
in translation efficiency. The difference between the translational
activities of the HCV-N and HCV-H transcripts was increased
when translation was carried out in reticulocyte lysates containing
high K+ concentrations, with a sevenfold difference evident
at 130 to 150 mM K+. These results suggest that there
is an RNA-RNA interaction involving 5'NTR and capsid-coding
sequences flanking the IRES and that this is responsible for
the reduced IRES activity of the genotype 1b virus, HCV-N.